Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Lantheus Holdings Inc LNTH

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus Holdings Announces Presentations at the 33rd Annual European Association of Nuclear Medicine (EANM) Virtual Congress

Business Wire October 8, 2020

Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL(TM) (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent

Business Wire September 30, 2020

Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference

Business Wire September 3, 2020

Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY®

Business Wire August 12, 2020

Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results

Business Wire July 30, 2020

Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time

Business Wire July 23, 2020

Lantheus Holdings to Showcase the Potential of PyL(TM) Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting

Business Wire July 1, 2020

Lantheus Completes Merger with Progenics

Business Wire June 22, 2020

Independent Bank Group Set to Join S&P SmallCap 600

PR Newswire June 17, 2020

Lantheus Stockholders Approve Share Issuance For Merger with Progenics

Business Wire June 16, 2020

Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference

Business Wire June 16, 2020

SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.

PR Newswire May 27, 2020

Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference

Business Wire May 20, 2020

Lantheus Holdings to Present at the UBS Virtual Global Healthcare Conference

Business Wire May 5, 2020

Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results

Business Wire April 30, 2020

Lantheus Holdings to Host First Quarter 2020 Earnings Conference Call on April 30, 2020 at 8:00 a.m. Eastern Time

Business Wire April 16, 2020

Velan Capital Agrees to Support Merger of Lantheus and Progenics

Business Wire April 14, 2020

Lantheus Holdings, Inc. Reports Preliminary Q1 Revenue Near Top End of Previously Disclosed Guidance Range; Withdraws 2020 Financial Guidance

Business Wire April 9, 2020

Lantheus Holdings, Inc. to Hold 2020 Annual Meeting of Stockholders Virtually

Business Wire April 6, 2020

Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger

Business Wire April 2, 2020